Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | CFO & COO | October 01, 2026 | October 05, 2026 |
| VERACYTE, INC.VCYT · Entity 2018 | COO / CFO | March 02, 2021 | March 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 208,686 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Tax withholding · Disposed 3,018 · Balance 208,686 F1: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
VERACYTE, INC.
Report date March 02, 2021 · Filed March 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 116,858 |
Reported balance
After 2021-03-02 transaction · row 1
1 source rowRow 1 · 2021-03-02 · Tax withholding · Disposed 5,783 · Balance 116,858 F1: The reporting person is reporting the withholding of 284, 220, 3,519, 440 and 1,320 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 644, 500, 8,000, 1,000 and 3,000 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019, February 28, 2019, July 1, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of 284, 220, 3,519, 440 and 1,320 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 644, 500, 8,000, 1,000 and 3,000 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019, February 28, 2019, July 1, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 22:47 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 3,018 | $66.23 | $199,882.14 |
DisclosureSEC source: 0001543503-26-000007 · form4-10052026_101057.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,686 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| September 12, 2026 Filed Sep 15, 2026 21:11 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 8,220 | $52.37 | $430,481.40 |
DisclosureSEC source: 0001543503-26-000006 · form4-09152026_090934.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,704 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:00 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,930 | $29.25 | $85,702.50 |
DisclosureSEC source: 0001543503-26-000004 · form4-07022026_080706.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,924 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. F2 · balance_after: Includes 1,306 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 20:05 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 24,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001543503-26-000003 · form4-04222026_040405.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,548 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the RSUs will be vested on the third anniversary of April 6, 2027, subject to the Reporting Person's continuous employment on each applicable vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:04 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 11,725 | $17.87 | $209,525.75 |
DisclosureSEC source: 0001543503-26-000002 · form4-04032026_080422.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · CFO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,414 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:24 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 4,644 | $20.42 | $94,830.48 |
DisclosureSEC source: 0001543503-26-000001 · form4-02042026_090248.xml · nonDerivative · entry 3 Kennedy Keith · CIK 0001543503 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,139 F3 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:24 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 14,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001543503-26-000001 · form4-02042026_090248.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,783 F2 · shares: The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human Capital Committee of the Issuer's Board of Directors on February 2, 2026. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:24 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001543503-26-000001 · form4-02042026_090248.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,309 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the RSUs will be vested on the third anniversary of April 6, 2027, subject to the Reporting Person's continuous employment on each applicable vesting date. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 20:01 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 7,987 | $13.53 | $108,064.11 |
DisclosureSEC source: 0001543503-25-000006 · form4-09152025_080953.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,309 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:34 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 77,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001543503-25-000002 · wk-form4_1742934827.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,296 F1 · shares: The reported securities are represented by restricted stock units, of which one-third will vest on April 1, 2026 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the restricted stock units will be vested on the third anniversary of April 1, 2026, subject to the Reporting Person's continuous employment on each applicable vesting date. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 20:45 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantEmployee Stock Option (right to buy) · Derivative | 100,651 | $0.00 Strike: $29.43 | $0.00 |
DisclosureSEC source: 0001543503-24-000005 · wk-form4_1726519530.xml · derivative · entry 2 Kennedy Keith · CIK 0001543503 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,651 Underlying: Common Stock · 100,651 shares Expires 2034-09-12 F2 · derivative.exercise_date: 1/4th of the shares subject to this option shall vest on September 12, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter through September 30, 2028. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 20:45 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 70,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001543503-24-000005 · wk-form4_1726519530.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,101 F1 · shares: The reported securities are represented by restricted stock units, which will vest in four equal annual installments on the anniversary of the grant date until fully vested on September 12, 2028. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 22:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 5,783 | $62.15 | $359,413.45 |
DisclosureSEC source: 0001384101-21-000040 · wf-form4_161489582980243.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,858 F1 · kind: The reporting person is reporting the withholding of 284, 220, 3,519, 440 and 1,320 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 644, 500, 8,000, 1,000 and 3,000 Restricted Stock Units, respectively, granted on March 2, 2018, February 28, 2019, February 28, 2019, July 1, 2019 and February 28, 2020 respectively, and does not represent a sale by the reporting person. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 22:23 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $58.06 | $0.00 |
DisclosureSEC source: 0001384101-21-000030 · wf-form4_161472375502966.xml · derivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-02-26 F2 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 26, 2022, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 22:23 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-21-000030 · wf-form4_161472375502966.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,641 F1 · kind: Restricted stock units awarded on February 26, 2021 vest 25% on March 2, 2022 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 11,046 | $62.30 | $688,165.80 |
DisclosureSEC source: 0001384101-21-000018 · wf-form4_161437529534781.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,641 F1 · shares: The reporting person is reporting the withholding of 11,046 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 25,000 Performance Stock Units vested on February 24, 2021 and does not represent a sale by the reporting person. F2 · balance_after: Includes 570 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 22:55 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 944 | $55.08 | $51,995.52 |
DisclosureSEC source: 0001437749-20-024884 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,117 F1 · kind: The reporting person is reporting the withholding of 440, 284 and 220 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,000, 644 and 500 Restricted Stock Units, respectively granted on July 1, 2019, March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 21:11 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,131 | $34.16 | $38,634.96 |
DisclosureSEC source: 0001437749-20-019357 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,061 F1 · kind: The reporting person is reporting the withholding of 527, 340 and 264 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,000, 643 and 500 Restricted Stock Units, respectively granted on July 2, 2019, March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person. F2 · balance_after: Includes 560 shares of common stock purchased on July 31, 2020 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 15,416 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · derivative · entry 10 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,584 Underlying: Common Stock · 15,416 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F6 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 22,167 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · derivative · entry 9 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,223 Underlying: Common Stock · 22,167 shares Expires 2026-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F5 · derivative.exercise_date: The option began to vest on December 6, 2017 and vests at a rate of 1/36th per total number of shares subject to the award each month, subject to the continuing employment of the reporting person on the vesting date. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 10,075 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · derivative · entry 8 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,017 Underlying: Common Stock · 10,075 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F4 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 80,677 | $28.21 | $2,276,172.47 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 6 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,632 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.58. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 15,416 | $9.05 | $139,514.80 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 5 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 22,167 | $7.47 | $165,587.49 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 4 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 21:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 10,075 | $5.98 | $60,248.50 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 3 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 2,800 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · derivative · entry 7 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,092 Underlying: Common Stock · 2,800 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F4 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 5,747 | $28.02 | $161,040.14 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,651 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.15. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:47 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 2,800 | $5.98 | $16,744.00 |
DisclosureSEC source: 0001437749-20-014799 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:40 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,106 | $26.73 | $56,293.38 |
DisclosureSEC source: 0001437749-20-014544 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,598 F1 · kind: The reporting person is reporting the withholding of 2,106 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 4,000 Restricted Stock Units granted on July 1, 2019 and does not represent a sale by the reporting person. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:15 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 603 | $26.01 | $15,684.03 |
DisclosureSEC source: 0001384101-20-000078 · wf-form4_159130169726252.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,704 F1 · kind: The reporting person is reporting the withholding of 339 and 264 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 643 and 500 Restricted Stock Units, respectively granted on March 2, 2018 and February 28, 2019, respectively, and does not represent a sale by the reporting person. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $26.55 | $0.00 |
DisclosureSEC source: 0001384101-20-000065 · wf-form4_158940318286618.xml · derivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2030-05-10 F2 · derivative.exercise_date: The stock options awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000065 · wf-form4_158940318286618.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,307 F1 · kind: Restricted stock units awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000031 · wf-form4_158327596412675.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,007 F2 · kind: Shares relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. The Reporting Person did not sell or otherwise dispose of the shares for any reason other than to cover required taxes. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $24.69 | $0.00 |
DisclosureSEC source: 0001384101-20-000031 · wf-form4_158327596412675.xml · derivative · entry 3 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2030-02-27 F3 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000031 · wf-form4_158327596412675.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,400 F1 · kind: Restricted stock units awarded on February 28, 2020 vest 25% on March 2, 2021 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:15 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 13,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000023 · wf-form4_158275169815441.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,400 F3 · kind: The reporting person is reporting the withholding of 13,163 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 25,000 Performance Stock Units vested on February 24, 2020 and does not represent a sale by the reporting person. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:15 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000023 · wf-form4_158275169815441.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,563 F1 · kind: Represents the acquisition of restricted stock units ("RSUs") earned by the Reporting Person upon the achievement of performance goals for the one-year period ended December 31, 2019, as reflected in the financial statements certified by the Audit Committee of the Board of Directors on February 24, 2020. The RSUs vested as to 50% of the total RSUs earned on February 24, 2020, and the remaining 50% of the RSUs will vest on February 24, 2021, subject to the Reporting Person's continuous service to the Issuer through such date. F2 · balance_after: Includes 860 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan on January 31, 2020. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 21:23 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 7,052 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001384101-20-000006 · wf-form4_157964179339719.xml · derivative · entry 3 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,390 Underlying: Common Stock · 7,052 shares Expires 2026-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · derivative.exercise_date: The option began to vest on December 6, 2017 and vests at a rate of 1/36th per total number of shares subject to the award each month, subject to the continuing employment of the reporting person on the vesting date. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 21:23 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 7,052 | $30.08 | $212,104.41 |
DisclosureSEC source: 0001384101-20-000006 · wf-form4_157964179339719.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,703 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.21. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| January 16, 2020 Filed Jan 21, 2020 21:23 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 7,052 | $7.47 | $52,678.44 |
DisclosureSEC source: 0001384101-20-000006 · wf-form4_157964179339719.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| December 27, 2019 Filed Dec 31, 2019 21:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 400 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001384101-19-000170 · wf-form4_157782652135141.xml · derivative · entry 3 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,442 Underlying: Common Stock · 400 shares Expires 2026-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · derivative.exercise_date: The option began to vest on December 6, 2017 and vests at a rate of 1/36th of the total number of shares subject to the award each month, subject to the continuing employment of the reporting person on each vesting date. Read SEC document |
| December 27, 2019 Filed Dec 31, 2019 21:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 400 | $30.00 | $12,001.96 |
DisclosureSEC source: 0001384101-19-000170 · wf-form4_157782652135141.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,703 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.02. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 27, 2019 Filed Dec 31, 2019 21:09 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 400 | $7.47 | $2,988.00 |
DisclosureSEC source: 0001384101-19-000170 · wf-form4_157782652135141.xml · nonDerivative · entry 1 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 21:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleStock Option (right to buy) · Derivative | 13,851 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001384101-19-000158 · wf-form4_157592591191238.xml · derivative · entry 8 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,842 Underlying: Common Stock · 13,851 shares Expires 2026-12-05 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: Beginning on December 6, 2017, 1/36 of the of shares vest each month for the following 36 months. Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 21:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 13,851 | $30.04 | $416,146.37 |
DisclosureSEC source: 0001384101-19-000158 · wf-form4_157592591191238.xml · nonDerivative · entry 5 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,703 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.50. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 21:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 13,851 | $7.47 | $103,466.97 |
DisclosureSEC source: 0001384101-19-000158 · wf-form4_157592591191238.xml · nonDerivative · entry 4 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 7,358 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001384101-19-000158 · wf-form4_157592591191238.xml · derivative · entry 7 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,892 Underlying: Common Stock · 7,358 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F5 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 11,942 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001384101-19-000158 · wf-form4_157592591191238.xml · derivative · entry 6 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,693 Underlying: Common Stock · 11,942 shares Expires 2026-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F4 · derivative.exercise_date: Beginning on December 6, 2017, 1/36 of the of shares vest each month for the following 36 months. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 19,300 | $30.00 | $579,069.48 |
DisclosureSEC source: 0001384101-19-000158 · wf-form4_157592591191238.xml · nonDerivative · entry 3 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,703 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 7,358 | $5.98 | $44,000.84 |
DisclosureSEC source: 0001384101-19-000158 · wf-form4_157592591191238.xml · nonDerivative · entry 2 Kennedy Keith · CIK 0001543503 · COO / CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.